269 related articles for article (PubMed ID: 23663320)
1. Normal cognition in transgenic BRI2-Aβ mice.
Kim J; Chakrabarty P; Hanna A; March A; Dickson DW; Borchelt DR; Golde T; Janus C
Mol Neurodegener; 2013 May; 8():15. PubMed ID: 23663320
[TBL] [Abstract][Full Text] [Related]
2. BRI2 protein regulates β-amyloid degradation by increasing levels of secreted insulin-degrading enzyme (IDE).
Kilger E; Buehler A; Woelfing H; Kumar S; Kaeser SA; Nagarathinam A; Walter J; Jucker M; Coomaraswamy J
J Biol Chem; 2011 Oct; 286(43):37446-57. PubMed ID: 21873424
[TBL] [Abstract][Full Text] [Related]
3. BRI2 (ITM2b) inhibits Abeta deposition in vivo.
Kim J; Miller VM; Levites Y; West KJ; Zwizinski CW; Moore BD; Troendle FJ; Bann M; Verbeeck C; Price RW; Smithson L; Sonoda L; Wagg K; Rangachari V; Zou F; Younkin SG; Graff-Radford N; Dickson D; Rosenberry T; Golde TE
J Neurosci; 2008 Jun; 28(23):6030-6. PubMed ID: 18524908
[TBL] [Abstract][Full Text] [Related]
4. Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer's disease.
Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM
BMC Neurosci; 2019 Mar; 20(1):13. PubMed ID: 30894120
[TBL] [Abstract][Full Text] [Related]
5. Amyloid precursor protein processing and retinal pathology in mouse models of Alzheimer's disease.
Dutescu RM; Li QX; Crowston J; Masters CL; Baird PN; Culvenor JG
Graefes Arch Clin Exp Ophthalmol; 2009 Sep; 247(9):1213-21. PubMed ID: 19271231
[TBL] [Abstract][Full Text] [Related]
6. Reduction of beta-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease.
Paris D; Ganey NJ; Laporte V; Patel NS; Beaulieu-Abdelahad D; Bachmeier C; March A; Ait-Ghezala G; Mullan MJ
J Neuroinflammation; 2010 Mar; 7():17. PubMed ID: 20211007
[TBL] [Abstract][Full Text] [Related]
7. The extracellular domain of Bri2 (ITM2B) binds the ABri peptide (1-23) and amyloid beta-peptide (Abeta1-40): Implications for Bri2 effects on processing of amyloid precursor protein and Abeta aggregation.
Peng S; Fitzen M; Jörnvall H; Johansson J
Biochem Biophys Res Commun; 2010 Mar; 393(3):356-61. PubMed ID: 20036644
[TBL] [Abstract][Full Text] [Related]
8. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
[TBL] [Abstract][Full Text] [Related]
9. A novel monoclonal antibody against the N-terminus of Aβ1-42 reduces plaques and improves cognition in a mouse model of Alzheimer's disease.
Xing HY; Li B; Peng D; Wang CY; Wang GY; Li P; Le YY; Wang JM; Ye G; Chen JH
PLoS One; 2017; 12(6):e0180076. PubMed ID: 28662102
[TBL] [Abstract][Full Text] [Related]
10. Short amyloid-beta (Abeta) immunogens reduce cerebral Abeta load and learning deficits in an Alzheimer's disease mouse model in the absence of an Abeta-specific cellular immune response.
Maier M; Seabrook TJ; Lazo ND; Jiang L; Das P; Janus C; Lemere CA
J Neurosci; 2006 May; 26(18):4717-28. PubMed ID: 16672644
[TBL] [Abstract][Full Text] [Related]
11. 27-hydroxycholesterol promotes Aβ accumulation via altering Aβ metabolism in mild cognitive impairment patients and APP/PS1 mice.
Zhang X; Xi Y; Yu H; An Y; Wang Y; Tao L; Wang Y; Liu W; Wang T; Xiao R
Brain Pathol; 2019 Jul; 29(4):558-573. PubMed ID: 30582229
[TBL] [Abstract][Full Text] [Related]
12. Reversible pathologic and cognitive phenotypes in an inducible model of Alzheimer-amyloidosis.
Melnikova T; Fromholt S; Kim H; Lee D; Xu G; Price A; Moore BD; Golde TE; Felsenstein KM; Savonenko A; Borchelt DR
J Neurosci; 2013 Feb; 33(9):3765-79. PubMed ID: 23447589
[TBL] [Abstract][Full Text] [Related]
13. Huannao Yicong decoction ameliorates cognitive deficits in APP/PS1/tau triple transgenic mice by interfering with neurotoxic interaction of Aβ-tau.
Zhang H; Chen W; Li Z; Huang Q; Wen J; Chang S; Pei H; Ma L; Li H
J Ethnopharmacol; 2024 Jan; 318(Pt B):116985. PubMed ID: 37532075
[TBL] [Abstract][Full Text] [Related]
14. Biochemical and behavioral characterization of the double transgenic mouse model (APPswe/PS1dE9) of Alzheimer's disease.
Xiong H; Callaghan D; Wodzinska J; Xu J; Premyslova M; Liu QY; Connelly J; Zhang W
Neurosci Bull; 2011 Aug; 27(4):221-32. PubMed ID: 21788993
[TBL] [Abstract][Full Text] [Related]
15. The type of Aβ-related neuronal degeneration differs between amyloid precursor protein (APP23) and amyloid β-peptide (APP48) transgenic mice.
Rijal Upadhaya A; Scheibe F; Kosterin I; Abramowski D; Gerth J; Kumar S; Liebau S; Yamaguchi H; Walter J; Staufenbiel M; Thal DR
Acta Neuropathol Commun; 2013 Nov; 1(1):77. PubMed ID: 24252227
[TBL] [Abstract][Full Text] [Related]
16. Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model.
Durairajan SS; Liu LF; Lu JH; Chen LL; Yuan Q; Chung SK; Huang L; Li XS; Huang JD; Li M
Neurobiol Aging; 2012 Dec; 33(12):2903-19. PubMed ID: 22459600
[TBL] [Abstract][Full Text] [Related]
17. APP heterozygosity averts memory deficit in knockin mice expressing the Danish dementia BRI2 mutant.
Tamayev R; Matsuda S; Giliberto L; Arancio O; D'Adamio L
EMBO J; 2011 May; 30(12):2501-9. PubMed ID: 21587206
[TBL] [Abstract][Full Text] [Related]
18. Pyroglutamation of amyloid-βx-42 (Aβx-42) followed by Aβ1-40 deposition underlies plaque polymorphism in progressing Alzheimer's disease pathology.
Michno W; Nyström S; Wehrli P; Lashley T; Brinkmalm G; Guerard L; Syvänen S; Sehlin D; Kaya I; Brinet D; Nilsson KPR; Hammarström P; Blennow K; Zetterberg H; Hanrieder J
J Biol Chem; 2019 Apr; 294(17):6719-6732. PubMed ID: 30814252
[TBL] [Abstract][Full Text] [Related]
19. Effects of alcohol intake on cognitive function and β-amyloid protein in APP/PS1 transgenic mice.
Gong YS; Hou FL; Guo J; Lin L; Zhu FY
Food Chem Toxicol; 2021 May; 151():112105. PubMed ID: 33737111
[TBL] [Abstract][Full Text] [Related]
20. N-truncated Aβ
Wirths O; Walter S; Kraus I; Klafki HW; Stazi M; Oberstein TJ; Ghiso J; Wiltfang J; Bayer TA; Weggen S
Alzheimers Res Ther; 2017 Oct; 9(1):80. PubMed ID: 28978359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
